LON:CLL Cello Health plc (CLL.L) (CLL) Share Price, News & Analysis GBX 161 0.00 (0.00%) (As of 08/11/2020) Add Compare Share Share Today's Range 161▼ 16150-Day Range 161▼ 16152-Week Range 100▼ 165VolumeN/AAverage Volume453,244 shsMarket Capitalization£178.84 millionP/E RatioN/ADividend Yield1.24%Price TargetN/A Stock AnalysisStock Analysis Get Cello Health plc (CLL.L) alerts: Email Address Ad Porter & CompanyWhy billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. Click here for my exclusive video About Cello Health plc (CLL.L) Stock (LON:CLL)Cello Health plc, together with its subsidiaries, provides marketing services in the United Kingdom, Rest of Europe, the United States, and internationally. It operates in two segments, Cello Health and Cello Signal. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients. The Cello Signal segment provides market research and direct communications services principally to consumer-facing clients. Cello Health plc was incorporated in 2004 and is headquartered in London, the United Kingdom.Read More CLL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLL Stock News HeadlinesApril 9, 2024 | forbes.comBest Virtual Therapy Services of 2024February 15, 2024 | forbes.comBest Gay Dating Sites Of 2024September 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…February 6, 2024 | health.usnews.comDr. Patrick L. CelloJanuary 30, 2024 | morningstar.comPrimary Health Properties PLCJanuary 5, 2024 | uk.investing.comProbiotix Health PLC (X90)December 22, 2023 | forbes.comBest Low-Carb Diet Meal Delivery Plans of 2023December 15, 2023 | health.usnews.comJessica L. JohnstonSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…December 2, 2023 | forbes.comHow Much Do Invisible Braces CostNovember 23, 2023 | forbes.comBest Dating Sites For Singles Over 50 in 2023November 1, 2023 | msn.comCello World IPO Subscribed 38% On Day 1October 27, 2023 | bbc.co.ukThe Bee CelloOctober 18, 2023 | msn.com8 Best Cellos for Beginners of 2023June 23, 2023 | finance.yahoo.comLTG.L - Learning Technologies Group plcJune 13, 2023 | uk.finance.yahoo.comPFD.L - Premier Foods plcMay 12, 2023 | investing.comTrellus Health PLC (TRLST)May 10, 2023 | investing.comRutherford Health PLC (RUTH)See More Headlines Receive CLL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cello Health plc (CLL.L) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorBusiness Services Industry Marketing Services Sub-IndustryN/A Current SymbolLON:CLL CUSIPN/A CIKN/A Webwww.cellogroup.com Phone+44-20-78128460FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio14.72 Current Ratio1.15 Quick Ratio1.11 Sales & Book Value Annual Sales£166.77 million Price / Sales1.07 Cash FlowGBX 8 per share Price / Cash Flow20.13 Book ValueGBX 77.60 per share Price / Book2.07Miscellaneous Outstanding Shares111,080,000Free FloatN/AMarket Cap£178.84 million OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Mark Scott (Age 53)CEO & Exec. Director Mr. Mark Bentley (Age 48)Group Fin. Director, Company Sec. & Exec. Director Mr. Stephen HighleyGroup COO & DirectorMr. Owen WilliamsManaging PartnerMr. Vincent NolanManaging PartnerKey CompetitorsTaptica InternationalLON:TAPArena Events GroupLON:AREBe Heard Group plc (BHRD.L)LON:BHRDAutomax MotorsLON:MTMY3971718 (UBM.L)LON:UBMView All Competitors CLL Stock Analysis - Frequently Asked Questions How have CLL shares performed this year? Cello Health plc (CLL.L)'s stock was trading at GBX 161 at the start of the year. Since then, CLL stock has increased by 0.0% and is now trading at GBX 161. View the best growth stocks for 2024 here. How do I buy shares of Cello Health plc (CLL.L)? Shares of CLL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Cello Health plc (CLL.L) own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cello Health plc (CLL.L) investors own include Lloyds Banking Group (LLOY), Sirius Minerals (SXX), Saga (SAGA), QinetiQ Group (QQ), (OPTR) (OPTR), Modern Water plc (MWG.L) (MWG) and IGas Energy (IGAS). This page (LON:CLL) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cello Health plc (CLL.L) Please log in to your account or sign up in order to add this asset to your watchlist. Share Cello Health plc (CLL.L) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.